Peptide Nasal Spray Guide: Selank, Semax, PT-141, Preparation, and Technique

The nasal route is one of the most underappreciated delivery methods in peptide therapy. For certain peptides — particularly those targeting the brain and central nervous system — nasal delivery offers a direct pathway that injectable administration cannot match. The olfactory nerves that transmit smell signals from the nasal mucosa extend directly into the brain, and small molecules administered intranasally can reach CNS tissue rapidly without first passing through the blood-brain barrier.

This guide covers the science of intranasal peptide delivery, the peptides best suited to this route, how to prepare and use nasal sprays correctly, and the practical differences in bioavailability and onset compared to injection.

Why the Nasal Route Matters for Peptides

Most peptide guides focus on subcutaneous injection because it offers reliable systemic bioavailability. But for peptides where the goal is CNS action — cognitive enhancement, anxiolytic effects, mood modulation, or sexual function — the nasal route has distinct advantages:

Direct CNS access: The olfactory epithelium is one of very few locations where the external environment is in direct proximity to brain tissue. Molecules transported along the olfactory nerve can reach the olfactory bulb and from there distribute to limbic structures, the cortex, and the hypothalamus.

Speed of onset: Intranasal peptides designed for CNS action typically show effects within 15–30 minutes — faster than subcutaneous injection for CNS endpoints, which must first enter systemic circulation before crossing into the brain.

Convenience: No needles, no sterile injection technique, no sharps disposal. A properly prepared nasal spray is portable and discreet.

Reduced systemic exposure: For peptides where peripheral effects are not desired — or where minimizing systemic exposure reduces side effects — the nasal route limits the dose reaching general circulation.

The main limitation is that intranasal bioavailability is variable. Nasal congestion, mucosal inflammation, spray technique, and the physicochemical properties of the peptide all affect how much reaches its target.

Selank: The Intranasal Anxiolytic

Selank is a synthetic heptapeptide developed in Russia and arguably the peptide with the longest track record of intranasal administration. It was developed specifically as a nasal formulation and has been used clinically in Russia for anxiety and cognitive complaints since the early 2000s.

Selank's primary effects include anxiolysis, mild cognitive enhancement, reduced neuroinflammation, and normalization of GABA-A receptor function. The nasal route delivers selank directly to limbic structures involved in anxiety processing — the amygdala and hippocampus — more efficiently than systemic injection.

Typical Selank Protocol

Standard selank nasal spray is prepared at a concentration of 300–750 mcg per 100 mcl (one standard spray pump delivers approximately 100 mcl). A typical dose is 1–2 sprays per nostril, once or twice daily.

For anxiety: 250–500 mcg total per dose, 1–2 times daily For cognitive enhancement: 300–600 mcg in the morning Cycle: 10–14 days on, 7 days off to maintain sensitivity

Semax: Cognitive and Neuroprotective Action

Semax is a synthetic peptide derived from the ACTH (adrenocorticotropic hormone) fragment 4-10. Its effects include cognitive enhancement, increased BDNF (brain-derived neurotrophic factor), neuroprotection, and improved attention and memory. Like selank, semax was developed specifically for nasal delivery and is used clinically in Russia for post-stroke rehabilitation and cognitive decline.

BDNF upregulation is one of semax's most notable effects. BDNF is critical for neuronal survival, synaptic plasticity, and learning — and intranasal semax increases BDNF expression in the hippocampus and cortex within hours of administration.

Typical Semax Protocol

Semax is available in two common forms: standard semax and N-acetyl semax (the acetylated form, which has longer activity and is considered more potent):

Standard semax: 200–600 mcg per dose, 1–2 times daily N-acetyl semax: 100–300 mcg per dose is typically sufficient given higher potency

For cognitive enhancement cycles: 2 weeks on, 1–2 weeks off For neuroprotective purposes: continuous low-dose use (200 mcg/day) with periodic breaks

PT-141 (Bremelanotide): Sexual Function via Nasal Delivery

PT-141, or bremelanotide, is a melanocortin receptor agonist with documented effects on sexual arousal in both men and women. Unlike PDE5 inhibitors (Viagra, Cialis), PT-141 acts centrally — through hypothalamic melanocortin receptors — rather than peripherally on vascular tissue. This means it can increase sexual desire and arousal even in people for whom blood flow is not the limiting factor.

PT-141 was originally developed as a nasal spray (under the name Palatin Technologies PT-141) before being reformulated as a subcutaneous injection for FDA approval. The nasal formulation remains in use through compounding pharmacies and is preferred by some users for its convenience and rapid onset.

PT-141 Nasal Spray Dosing

Typical nasal doses range from 500–2000 mcg, administered 45–90 minutes before desired effect. The nasal route produces a faster onset than subcutaneous injection.

Common side effects include transient facial flushing and nausea, which are dose-dependent and more pronounced at higher doses. Starting at 500 mcg and titrating up is strongly recommended. PT-141 should not be used more than once every 48–72 hours due to receptor desensitization.

How to Prepare Peptide Nasal Sprays

Preparing nasal sprays from lyophilized peptide powder requires attention to sterile technique and accurate measurement. This process is the same fundamental approach as reconstituting for injection, with a different final vehicle.

Equipment Needed

• Sterile nasal spray bottles (available from compounding supply vendors)
• Bacteriostatic water (as the diluent)
• Insulin syringe for accurate measurement
• Alcohol swabs

Step-by-Step Preparation

1. Calculate your target concentration: Decide how many mcg per spray you want. A standard nasal bottle delivers 100 mcl per pump. To get 300 mcg per spray, you need 3,000 mcg per ml.

2. Reconstitute the peptide: Following the same principles as any peptide reconstitution, add bacteriostatic water to the lyophilized powder. For selank and semax, bacteriostatic water is the standard diluent.

3. Fill the nasal spray bottle: Draw the reconstituted solution into a syringe and inject it into the sterile nasal spray bottle through the dip tube port or cap.

4. Label and store: Label with peptide name, concentration, and preparation date. Store in the refrigerator. Reconstituted peptides in bacteriostatic water are generally stable for 30–60 days when refrigerated.

Important Notes on Nasal Formulation

Some practitioners add small amounts of sodium chloride (saline) to match the osmolarity of nasal mucosa (approximately 0.9%), which can improve tolerability and reduce mucosal irritation. Preservative-free bacteriostatic water is preferred over plain sterile water because it extends shelf life.

Avoid adding any substances that could irritate the nasal mucosa: no DMSO, no ethanol carriers, no strong acids or bases. The goal is a clean aqueous solution.

Spray Technique

Proper technique significantly affects intranasal peptide delivery:

1. Blow your nose gently 10 minutes before administering to clear mucus without causing rebound congestion.
2. Position the nozzle at the base of the nostril, angled slightly toward the lateral wall of the nose rather than straight up toward the septum.
3. Breathe in gently through the nose as you spray — this distributes the spray throughout the nasal cavity rather than depositing it at the entrance.
4. Alternate nostrils for multi-dose protocols. If taking two sprays, use one in each nostril.
5. Avoid sniffing hard immediately after — this sends the peptide to the throat where it is swallowed and may be degraded before CNS absorption.
6. Remain upright for at least 5 minutes after administration.

Bioavailability Comparison

Intranasal bioavailability is generally lower and more variable than subcutaneous injection but superior for CNS-targeted effects:

| Peptide | Intranasal CNS Bioavailability | Subcutaneous CNS Bioavailability | |---|---|---| | Selank | High (purpose-designed) | Moderate | | Semax | High (purpose-designed) | Moderate | | PT-141 | Moderate-High | High (systemic) | | BPC-157 | Low | Low (CNS) / High (peripheral) | | Oxytocin | Moderate | Low (CNS) |

Frequently Asked Questions

Q: Can any peptide be used as a nasal spray? Not all peptides are suitable for intranasal delivery. Candidates should be small enough and lipophilic enough to cross nasal membranes, stable in aqueous solution, and tolerable to nasal mucosa. Selank, semax, and PT-141 were specifically developed for this route.

Q: How do I know if my nasal spray is working? Effects typically appear within 20–40 minutes. Selank produces a subtle sense of calm without sedation. Semax may produce increased alertness or mental clarity. PT-141 produces arousal within 60–90 minutes. If you notice nothing after 3–5 uses, reassess your dose and technique.

Q: Can I use peptide nasal sprays with nasal congestion? Congestion reduces absorption by limiting surface area contact. Clear congestion with saline rinse before use if possible. Avoid using intranasal peptides immediately after using nasal decongestant sprays, as these can temporarily damage the mucosal surface.

Q: How long do prepared nasal sprays last? Refrigerated in bacteriostatic water, most peptide nasal sprays remain stable for 30–45 days. Discard if you notice precipitation, discoloration, or unusual odor.

Q: Is intranasal delivery safer than injection? There is no systemic sterility risk with intranasal delivery (no injection site infections), but the peptide itself is no "safer" — it reaches target tissues and produces real biological effects. Always start with the lowest effective dose regardless of route.